2m 2m 2m 2m 2m 2m 2m
CVRX (CVRX)
NASDAQ
$5.40-$0.03 (-0.55%)
Price as of Jun 03, 2026 6:53 PM EDT- $148.1MMarket Cap
- -19.67%1-Year Change
- Medical DevicesIndustry
CVRX (CVRX)
$5.40-$0.03 (-0.55%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 56.7M +10.45% | 51.3M +30.53% | 39.3M +74.89% | 22.5M +72.36% | |
Cost of Revenue | 8.3M -0.28% | 8.3M +33.22% | 6.3M +25.15% | 5.0M +37.34% | |
Gross Profit | 48.3M +12.53% | 43.0M +30.02% | 33.0M +89.12% | 17.5M +85.93% | |
Sales and Marketing Expense | 88.5M -3.11% | 91.3M +41.56% | 64.5M +28.90% | 50.0M +79.61% | |
Research and Development Expense | -11.1M +0.009% | -11.1M -4.32% | -11.6M +16.89% | -10.0M +32.68% | |
Depreciation and Amortization Expense | 756,000 +22.13% | 619,000 +18.58% | 522,000 +26.70% | 412,000 +145.24% | |
Total Operating Expenses | 99.6M -2.78% | 102.4M +34.55% | 76.1M +26.91% | 60.0M +69.66% | |
Operating Profit | -51.3M -13.83% | -59.5M +38.02% | -43.1M +1.35% | -42.5M +63.77% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -1.8M +990.30% | -165,000 -92.56% | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -1.8M +990.30% | -165,000 -92.56% | |
Total Nonoperating Income and Expense | 3.8M -5.26% | 4.0M +3.30% | 3.9M +180.41% | 1.4M +109.28% | |
Income before Taxes | -53.3M -10.99% | -59.9M +45.94% | -41.1M -0.65% | -41.3M -3.88% | |
Income Taxes | -18,000 -132.73% | 55,000 -62.59% | 147,000 +34.86% | 109,000 +19.78% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -53.3M -11.10% | -60.0M +45.55% | -41.2M -0.55% | -41.4M -3.83% | |
Net Income from Continuing Operations Applicable to Common | -53.3M -10.99% | -59.9M +45.94% | -41.1M -0.65% | -41.3M -3.88% | |
Basic EPS and Net Income | -2.04 -23.02% | -2.65 +33.17% | -1.99 -1.49% | -2.02 -51.44% | |
Diluted EPS and Net Income | -2.04 -23.02% | -2.65 +33.17% | -1.99 -1.49% | -2.02 -51.44% | |
Basic Weighted Average Shares | 26.1M +15.44% | 22.6M +8.87% | 20.8M +1.08% | 20.5M +98.19% | |
Diluted Weighted Average Shares | 26.1M +15.44% | 22.6M +8.87% | 20.8M +1.08% | 20.5M +98.19% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 75.7M -28.53% | 105.9M +16.96% | 90.6M -14.71% | 106.2M -25.25% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 75.7M -28.53% | 105.9M +16.96% | 90.6M -14.71% | 106.2M -25.25% | |
Total Current Assets | 101.6M -21.70% | 129.8M +15.81% | 112.1M -8.78% | 122.9M -18.68% | |
Accumulated Depreciation | 4.1M +21.75% | 3.4M +22.20% | 2.8M +22.28% | 2.3M +22.06% | |
Property and Plant and Equipment and Net | 2.2M -10.46% | 2.5M +42.09% | 1.8M +3.83% | 1.7M +19.16% | |
Total Long-Term Assets | 26,000 -3.70% | 27,000 0.00% | 27,000 0.00% | 27,000 +3.85% | |
Total Assets | 104.8M -21.45% | 133.4M +15.78% | 115.2M -7.77% | 124.9M -18.10% | |
Income Taxes Payable | 93,000 -31.11% | 135,000 +8.00% | 125,000 +4.17% | 120,000 -65.81% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 13.3M +23.74% | 10.8M +36.85% | 7.9M -2.77% | 8.1M +36.90% | |
Total Long-Term Debt | 49.5M +0.49% | 49.3M +68.62% | 29.2M +333.11% | 6.7M N/A | |
Total Long-Term Liabilities | 2.0M +38.29% | 1.4M +39.67% | 1.0M +28.70% | 805,000 +18.21% | |
Total Liabilities | 65.5M +4.99% | 62.4M +58.75% | 39.3M +149.30% | 15.8M +139.14% | |
Retained Earnings | -590.7M +9.92% | -537.3M +12.56% | -477.4M +9.45% | -436.2M +10.49% | |
Total Stockholders Equity | 39.3M -44.66% | 71.1M -6.44% | 75.9M -30.44% | 109.2M -25.20% | |
Total Shares Outstanding | 26.3M +3.90% | 25.3M +21.29% | 20.9M +1.19% | 20.6M +1.15% | |
Cash Flow | |||||
Cash from Operating Activities | -40.2M +2.62% | -39.1M +0.32% | -39.0M -8.57% | -42.7M +53.89% | |
Capital Expenditures | 580,000 -57.38% | 1.4M +130.29% | 591,000 -13.72% | 685,000 -42.10% | |
Cash from Investing Activities | -580,000 -57.38% | -1.4M +130.29% | -591,000 -13.72% | -685,000 -42.10% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 10.5M -81.17% | 55.9M +132.95% | 24.0M +220.09% | 7.5M -93.30% | |
Financials Ratio | |||||
Gross Margin | 85.33% +1.88% | 83.75% -0.39% | 84.08% +8.14% | 77.75% N/A | |
Operating Margin | -90.49% -21.98% | -115.98% +5.74% | -109.69% -42.05% | -189.27% N/A | |
Return on Assets | -44.76% -7.21% | -48.23% +40.59% | -34.31% +14.90% | -29.86% N/A | |
Return on Equity | -96.59% +18.39% | -81.58% +83.30% | -44.51% +37.06% | -32.47% N/A | |
Revenue Growth | 10.45% -65.78% | 30.53% -59.23% | 74.89% +3.49% | 72.36% N/A | |
Current Ratio | 7.63 -36.72% | 12.06 -15.37% | 14.25 -6.18% | 15.19 N/A | |
Cash Ratio | 5.69 -42.24% | 9.84 -14.53% | 11.52 -12.28% | 13.13 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow